EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Incorporating microbial cell-free DNA testing into healthcare-associated invasive fungal infection surveillance: benefits and challenges

Daniel Z Uslan iD, Ishminder Kaur iD, Omai B Garner iD, Shangxin Yang

Infection Control & Hospital Epidemiology · 2025

DOI: 10.1017/ice.2025.48 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Daniel Z Uslan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Hauptthemen laut MEDLINE: Invasive Fungal Infections, Cross Infection, Cell-Free Nucleic Acids, DNA, Fungal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Surveillance by clinical epidemiology teams for invasive fungal infections (IFIs) in healthcare settings can be challenging due to several factors including low sensitivity of noninvasive conventional microbiologic diagnostics, nonspecific clinical presentation, and complex patient populations. Recently, availability of microbial cell-free DNA testing (cfDNA) via the Karius Test has shown promise for increased diagnostic sensitivity of IFIs. However, how to best incorporate cfDNA results into IFI surveillance remains a vexing challenge. Herein, we provide perspectives on the benefits and challenges of use of cfDNA for IFI surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Invasive Fungal InfectionsCross InfectionCell-Free Nucleic AcidsDNA, FungalHumansSensitivity and Specificity

Stichwörter der Autor:innen

Karius testfungal diagnosticsmicrobial cell-free DNAsurveillance

Substanzen

Cell-Free Nucleic AcidsDNA, Fungal

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Clinical Epidemiology & Infection Prevention, UCLA Health, Los Angeles, CA, USA.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

ORCID-Profile: Daniel Z Uslan, Ishminder Kaur, Omai B Garner

Zitieren

APA

Uslan, D. Z., Kaur, I., Garner, O. B., & Yang, S. (2025). Incorporating microbial cell-free DNA testing into healthcare-associated invasive fungal infection surveillance: benefits and challenges. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2025.48

Vancouver

Uslan DZ, Kaur I, Garner OB, Yang S. Incorporating microbial cell-free DNA testing into healthcare-associated invasive fungal infection surveillance: benefits and challenges. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2025.48

BibTeX
@article{Uslan2025,
  author = {Uslan, Daniel Z and Kaur, Ishminder and Garner, Omai B and Yang, Shangxin},
  title = {Incorporating microbial cell-free DNA testing into healthcare-associated invasive fungal infection surveillance: benefits and challenges},
  journal = {Infection Control & Hospital Epidemiology},
  year = {2025},
  doi = {10.1017/ice.2025.48}
}
Kostenlos starten →